Haematologica (Jan 2017)
APOL1, α-thalassemia, and BCL11A variants as a genetic risk profile for progression of chronic kidney disease in sickle cell anemia
- Santosh L. Saraf,
- Binal N. Shah,
- Xu Zhang,
- Jin Han,
- Bamidele O. Tayo,
- Taimur Abbasi,
- Adam Ostrower,
- Elizabeth Guzman,
- Robert E. Molokie,
- Michel Gowhari,
- Johara Hassan,
- Shivi Jain,
- Richard S. Cooper,
- Roberto F. Machado,
- James P. Lash,
- Victor R. Gordeuk
Affiliations
- Santosh L. Saraf
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Binal N. Shah
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Xu Zhang
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Jin Han
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA;Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, IL, USA
- Bamidele O. Tayo
- Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
- Taimur Abbasi
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
- Adam Ostrower
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
- Elizabeth Guzman
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Robert E. Molokie
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Michel Gowhari
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Johara Hassan
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Shivi Jain
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- Richard S. Cooper
- Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
- Roberto F. Machado
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Illinois at Chicago, IL, USA
- James P. Lash
- Division of Nephrology, Department of Medicine, University of Illinois at Chicago, IL, USA
- Victor R. Gordeuk
- Division of Hematology & Oncology, Department of Medicine, Comprehensive Sickle Cell Center, University of Illinois at Chicago, IL, USA
- DOI
- https://doi.org/10.3324/haematol.2016.154153
- Journal volume & issue
-
Vol. 102,
no. 1
Abstract
No abstracts available.